Skip to main content

Advertisement

Log in

Impact of platelet transfusions in children with post-diarrheal hemolytic uremic syndrome

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Background

Platelet transfusions should be avoided in children with post-diarrheal hemolytic uremic syndrome (D + HUS) because they might increase microthrombi formation, thereby aggravating the disease. As this possibility has not yet been explored, we investigated whether platelet transfusion in patients with D + HUS would lead to a worse disease course compared to that in patients who did not receive platelet transfusion.

Methods

This was a case–control study in which data from D + HUS children who received platelet transfusions (cases, n  =  23) and those who did not (controls, n  =  54) were retrospectively reviewed and compared.

Results

Both patient groups were similar in age (p = 0.3), gender (p  =  0.53), weight (p  =  0.86), height (p  =  0.45), prior use of non-steroidal anti-inflammatory drugs (p  =  0.59) or antibiotics (p  =  0.45) and presence of dehydration at admission (p  =  0.79). The two groups also did not differ in initial leukocyte count (p  =  0.98), hematocrit (p  =  0.44) and sodium (p  =  0.11) and alanine aminotransferase levels (p  =  0.11). During hospitalization, dialysis duration (p  =  0.08), number of erythrocyte transfusions (p  =  0.2), serum creatinine peak (p  =  0.22), presence of severe bowel (p  =  0.43) or neurologic (p  =  0.97) injury, arterial hypertension (p  =  0.71), need for intensive care (p  =  0.33) and death (p  =  1.00) were also comparable.

Conclusion

Our findings suggest that platelet transfusion does not aggravate the course of the disease. Conversely, no hemorrhagic complications were observed in the group of patients who did not receive a platelet transfusion. Until these observations are confirmed by further studies, the benefits and risk of platelet transfusion should be thoughtfully balanced on an individual case basis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Scheiring J, Andreoli SP, Zimmerhackl LB (2008) Treatment and outcome of Shiga-toxin-associated Hemolytic Uremic Syndrome (HUS). Pediatr Nephrol 23(10):1749–1760

    Article  PubMed  Google Scholar 

  2. Scheiring J, Rosales A, Zimmerhackl LB (2010) Clinical practice. Today’s understanding of the haemolytic uraemic syndrome. Eur J Pediatr 169(1):7–13

    Article  PubMed  Google Scholar 

  3. Tarr PI (2009) Shiga toxin-associated hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: distinct mechanisms of pathogenesis. Kidney Int 75[Suppl 112]:S29–S32

    Article  Google Scholar 

  4. Tarr PI, Gordon CA, Chandler WL (2005) Shiga-toxin-producing Escherichia coli and haemolytic uremic syndrome. Lancet 365(9464):1073–1086

    PubMed  CAS  Google Scholar 

  5. Chandler WL, Jelacic S, Boster DR, Ciol MA, Williams GD, Watkins SL, Igarashi T, Tarr PI (2002) Prothrombotic coagulation abnormalities preceding the hemolytic-uremic syndrome. N Engl J Med 346(1):23–32

    Article  PubMed  CAS  Google Scholar 

  6. Seltz LB, Bakel LA, Tiehen J, Gao D, Cadnapaphornchai MA, Lum G, Ford D (2012) Efficacy and safety of clopidogrel in children with diarrhea associated hemolytic uremic syndrome. Thromb Res 130(3):e26–e30

    Article  PubMed  CAS  Google Scholar 

  7. Ray P, Liu XH (2001) Pathogenesis of Shiga toxin-induced hemolytic uremic syndrome. Pediatr Nephrol 16:823–839

    Article  PubMed  CAS  Google Scholar 

  8. Zoja C, Buelli S, Morigi M (2010) Shiga toxin-associated hemolytic uremic syndrome: pathophysiology of endothelial dysfunction. Pediatr Nephrol 25:2231–2240

    Article  PubMed  Google Scholar 

  9. Keir L, Coward RJ (2011) Advances in our understanding of the pathogenesis of glomerular thrombotic microangiopathy. Pediatr Nephrol 26(4):523–533

    Article  PubMed  Google Scholar 

  10. Tsai M, Kita A, Leach J, Rounsevell R, Huang JN, Moake J, Ware RE, Fletcher DA, Lam WA (2012) In vitro modeling of the microvascular occlusion and thrombosis that occur in hematologic diseases using microfluidic technology. J Clin Invest 122(1):408–418

    Article  PubMed  CAS  Google Scholar 

  11. Petruzziello TN, Mawji IA, Khan M, Marsden PA (2009) Verotoxin biology: molecular events in vascular endothelial injury. Kidney Int 75[Suppl 112]:S17–S19

    Article  Google Scholar 

  12. Gallo EG, Gianantonio CA (1995) Extrarenal involvement in diarrhoea-associated haemolytic-uraemic syndrome. Pediatr Nephrol 9(1):117–119

    Article  PubMed  CAS  Google Scholar 

  13. Iijima K, Kamioka I, Nozu K (2008) Management of diarrhea-associated hemolytic uremic syndrome in children. Clin Exp Nephrol 12(1):16–19

    Article  PubMed  Google Scholar 

  14. Karpman D, Papadopoulou D, Nilsson K, Sjögren AC, Mikaelsson C, Lethagen S (2001) Platelet activation by Shiga toxin and circulatory factors as a pathogenetic mechanism in the hemolytic uremic syndrome. Blood 97(10):3100–3108

    Article  PubMed  CAS  Google Scholar 

  15. Weil BR, Andreoli SP, Billmire DF (2010) Bleeding risk for surgical dialysis procedures in children with hemolytic uremic syndrome. Pediatr Nephrol 25(9):1693–1698

    Article  PubMed  Google Scholar 

  16. American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies (2006) Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology 105:198–208

    Article  Google Scholar 

  17. Development Task Force of the College of American Pathologists, (1994) Practice parameter for the use of fresh-frozen plasma, cryoprecipitate, and platelets. Fresh-frozen plasma, cryoprecipitate, and platelets administration practice guidelines development task force of the College of American Pathologists. JAMA 271:777–781

    Article  Google Scholar 

  18. Spizzirri FD, Rahman RC, Bibiloni N, Ruscasso J, Amoreo O (1997) Childhood hemolytic uremic syndrome in Argentina: long-term follow-up and pronostic features. Pediatr Nephrol 11(2):156–160

    Article  PubMed  CAS  Google Scholar 

  19. Caletti MG, Gallo G, Gianantonio CA (1996) Development of focal segmental sclerosis and hyalinosis in hemolytic uremic syndrome. Pediatr Nephrol 10:687–692

    Article  PubMed  CAS  Google Scholar 

  20. Balestracci A, Martin SM, Toledo I, Alvarado C, Wainsztein RE (2012) Dehydration at admission increased the need for dialysis in hemolytic uremic syndrome children. Pediatr Nephrol 27(8):1407–1410

    Article  PubMed  Google Scholar 

  21. Walters MD, Matthei IU, Kay R, Dillon MJ, Barratt TM (1989) The polymorphonuclear leucocyte count in childhood haemolytic uraemic syndrome. Pediatr Nephrol 3(2):130–134

    Article  PubMed  CAS  Google Scholar 

  22. Oakes R, Siegler R, McReynolds M, Pysher T, Pavia A (2006) Predictors of fatality in postdiarrheal hemolytic uremic syndrome. Pediatrics 117(5):1656–1662

    Article  PubMed  Google Scholar 

  23. Coad N, Marshall T, Rowe B, Taylor CM (1991) Changes in the postenteropathic form of the hemolytic uremic syndrome in children. Clin Nephrol 35(1):10–16

    PubMed  CAS  Google Scholar 

  24. Kamioka I, Yoshiya K, Satomura K, Kaito H, Fujita T, Iijima K, Nakanishi K, Yoshikawa N, Nozu K, Matsuo M, Japanese Society for Pediatric Nephrology (2008) Risk factors for developing severe clinical course in HUS patients: a national survey in Japan. Pediatr Int 50(4):441–446

    Article  PubMed  CAS  Google Scholar 

  25. Nathanson S, Kwon T, Elmaleh M, Charbit M, Launay EA, Harambat J, Brun M, Ranchin B, Bandin F, Cloarec S, Bourdat-Michel G, Piètrement C, Champion G, Ulinski T, Deschênes G (2010) Acute neurological involvement in diarrhea-associated hemolytic uremic syndrome. Clin J Am Soc Nephrol 5:1218–1228

    Article  PubMed  CAS  Google Scholar 

  26. Rahman RC, Cobeñas CJ, Drut R, Amoreo O, Ruscasso J, Spizzirri A, Suarez A, Zalba J, Ferrari C, Gatti M (2012) Hemorrhagic colitis in postdiarrheal hemolytic uremic syndrome: retrospective analysis of 54 children. Pediatr Nephrol 27(2):229–233

    Article  PubMed  Google Scholar 

  27. de Buys Roessingh AS, de Lagausie P, Baudoin V, Loirat C, Aigrain Y (2007) Gastrointestinal complications of post-diarrheal hemolytic uremic syndrome. Eur J Pediatr Surg 17(5):328–334

    Article  PubMed  Google Scholar 

  28. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114[Suppl 2]:S555–S576

    Google Scholar 

  29. Hanley JA, Lippman-Hand A (1983) If nothing goes wrong, is everything all right? Interpreting zero numerators. JAMA 249(13):1743–1745

    Article  PubMed  CAS  Google Scholar 

  30. Wong CS, Mooney JC, Brandt JR, Staples AO, Jelacic S, Boster DR, Watkins SL, Tarr PI (2012) Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: a multivariable analysis. Clin Infect Dis 55(1):33–41

    Article  PubMed  CAS  Google Scholar 

  31. Andreoli SP (2009) Acute kidney injury in children. Pediatr Nephrol 24(2):253–263

    Article  PubMed  Google Scholar 

  32. Bell BP, Griffin PM, Lozano P, Christie DL, Kobayashi JM, Tarr PI (1997) Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157:H7 infections. Pediatrics 100(1):E12

    Article  PubMed  CAS  Google Scholar 

  33. Grisaru S, Morgunov MA, Samuel SM, Midgley JP, Wade AW, Tee JB, Hamiwka LA (2011) Acute renal replacement therapy in children with diarrhea-associated hemolytic uremic syndrome: a single center 16 years of experience. Int J Nephrol 2011:930539

    PubMed  Google Scholar 

  34. Oh G, Lau KK (2011) Characteristics of children with sporadic hemolytic uremic syndrome in a single Northern California center. Int Urol Nephrol 44(5):1467–1472

    Article  PubMed  Google Scholar 

  35. Lumbreras Fernández J, Cruz Rojo J, Iñigo Martín G, Muley Alonso R, Vara Martín J (2010) Hemolytic uremic syndrome: long term renal injury. An Pediatr (Barc) 72(5):309–316

    Article  Google Scholar 

  36. Matsell DG, White CT (2009) An outbreak of diarrhea-associated childhood hemolytic uremic syndrome: the Walkerton epidemic. Kidney Int 75[Suppl 112]:S35–S37

    Article  Google Scholar 

Download references

Acknowledgments

The authors wish to thank Dr. Mariana Anderson for her kind assistance in preparing this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alejandro Balestracci.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Balestracci, A., Martin, S.M., Toledo, I. et al. Impact of platelet transfusions in children with post-diarrheal hemolytic uremic syndrome. Pediatr Nephrol 28, 919–925 (2013). https://doi.org/10.1007/s00467-013-2414-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-013-2414-y

Keywords

Navigation